Case Report: Fulminant meningococcus-meningitis under treatment with ravulizumab despite complete vaccination—a rare but severe complication
Objectives Complement C5 inhibitors such as ravulizumab are increasingly used for acetylcholine receptor–positive generalized myasthenia gravis (MG) but confer a relevant risk of invasive meningococcal infection. We report a rare case of fulminant meningococcal meningitis despite complete vaccination, highlighting the...